Product Information
SEROQUEL XR 300 MG TABLET is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $20.3527 per EA under NDC 00310028360. Its NADAC has been published 459 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the quetiapine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310028360
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
1/21/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA022047On Market Since
7/16/2007
Pharmacological Classes
Price Statistics
The NADAC for SEROQUEL XR 300 MG TABLET has been published 459 times since Nov 28, 2013, and over the history we have for it it has risen 25.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.3527 per EA |
|---|---|
| All-time high | $20.7247 (Sep 11, 2019) |
| All-time low | $16.0590 (Dec 18, 2013) |
| 52-week high | $20.5077 |
| 52-week low | $20.3527 |
| Median price | $20.4238 |
| Average price | $19.9307 |
| Largest weekly change | +10.0% (Jan 8, 2014) |
| Weeks tracked | 459 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SEROQUEL XR 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SEROQUEL XR 300 MG TABLET, manufactured by AstraZeneca Pharmaceuticals LP, is $20.3527 per EA (NDC 00310028360), effective Apr 1, 2026.
How has the price of SEROQUEL XR 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for SEROQUEL XR 300 MG TABLET has risen 25.2%. It has been tracked across 459 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SEROQUEL XR 300 MG TABLET?
Since Nov 28, 2013, the NADAC for SEROQUEL XR 300 MG TABLET has ranged from a low of $16.0590 (Dec 18, 2013) to a high of $20.7247 (Sep 11, 2019), with a median of $20.4238 per EA.
Are there cheaper alternatives to SEROQUEL XR 300 MG TABLET?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, QUETIAPINE FUMARATE 300 MG TAB, is $0.1442 per EA — about 99% below SEROQUEL XR 300 MG TABLET.
Who manufactures SEROQUEL XR 300 MG TABLET?
SEROQUEL XR 300 MG TABLET (NDC 00310028360) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.
Related Drugs
Same classification